Effect of drugs on the distribution of [14C]-5,6-dihydroxytryptamine and [14C]-5,7-dihydroxytryptamine in rat brain. 1978

H G Baumgarten, and H P Klemm, and L Lachenmayer, and H G Schlossberger

UI MeSH Term Description Entries
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002491 Central Nervous System Agents A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "nonspecific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (From Gilman AG, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p252) Central Nervous System Drugs
D002492 Central Nervous System Depressants A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents (antipsychotics and antianxiety agents). CNS Depressants,Depressants, CNS
D004102 Dihydroxytryptamines Tryptamine substituted with two hydroxyl groups in any position. Some are cytotoxic serotonin analogs that are preferentially taken up by serotonergic neurons and then destroy those neurons.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001345 Autoradiography The making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. (Dorland, 27th ed) Radioautography
D013347 Subcellular Fractions Components of a cell produced by various separation techniques which, though they disrupt the delicate anatomy of a cell, preserve the structure and physiology of its functioning constituents for biochemical and ultrastructural analysis. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p163) Fraction, Subcellular,Fractions, Subcellular,Subcellular Fraction
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D015115 5,6-Dihydroxytryptamine Tryptamine substituted with two hydroxyl groups in positions 5 and 6. It is a neurotoxic serotonin analog that destroys serotonergic neurons preferentially and is used in neuropharmacologic research. 3-(2-Aminoethyl)indole-5,6-diol,5,6 Dihydroxytryptamine
D015116 5,7-Dihydroxytryptamine Tryptamine substituted with two hydroxyl groups in positions 5 and 7. It is a neurotoxic serotonin analog that destroys serotonergic neurons preferentially and is used in neuropharmacology as a tool. 3-(2-Aminoethyl)-1H-indole-5,7-diol,5,7-Dihydroxytryptamine Creatine Sulfate,5,7 Dihydroxytryptamine,5,7 Dihydroxytryptamine Creatine Sulfate,Creatine Sulfate, 5,7-Dihydroxytryptamine,Sulfate, 5,7-Dihydroxytryptamine Creatine

Related Publications

H G Baumgarten, and H P Klemm, and L Lachenmayer, and H G Schlossberger
September 1984, Revista espanola de fisiologia,
H G Baumgarten, and H P Klemm, and L Lachenmayer, and H G Schlossberger
January 1975, Verhandlungen der Anatomischen Gesellschaft,
H G Baumgarten, and H P Klemm, and L Lachenmayer, and H G Schlossberger
May 1987, Journal of neurochemistry,
H G Baumgarten, and H P Klemm, and L Lachenmayer, and H G Schlossberger
January 1974, Advances in biochemical psychopharmacology,
H G Baumgarten, and H P Klemm, and L Lachenmayer, and H G Schlossberger
March 1994, Neuroendocrinology,
H G Baumgarten, and H P Klemm, and L Lachenmayer, and H G Schlossberger
January 1974, Advances in biochemical psychopharmacology,
H G Baumgarten, and H P Klemm, and L Lachenmayer, and H G Schlossberger
July 1973, Journal of neurochemistry,
H G Baumgarten, and H P Klemm, and L Lachenmayer, and H G Schlossberger
June 1978, Annals of the New York Academy of Sciences,
H G Baumgarten, and H P Klemm, and L Lachenmayer, and H G Schlossberger
March 1986, Brain research,
H G Baumgarten, and H P Klemm, and L Lachenmayer, and H G Schlossberger
January 1974, Cell and tissue research,
Copied contents to your clipboard!